Learn More
Multiple Myeloma (MM) patients are vulnerable to infections, which remain a major cause of death, including early death. During infection, human immune cells sense the presence of invading pathogens(More)
The therapeutic efficacy of antimyeloma agents, especially of immunomodulatory drugs (IMiDs), also relies on their ability to influence the tumor-host interaction by modulating immune response, while(More)
  • 1